Ivie Aifuwa

Ivie Aifuwa is a seasoned professional in the field of development engineering and automation, currently serving as Director at Bristol Myers Squibb since May 2021. Aifuwa has a strong background in cell therapy technologies and has led cross-functional teams to develop and implement innovative solutions in cell processing and manufacturing. Prior to this role, Aifuwa held various positions at Juno Therapeutics, Inc., and Amgen, focusing on biochemical assays and therapeutic antibody characterization. Aifuwa has also gained experience through internships at Novartis, contributing to process safety and drug formulation optimization. Aifuwa holds a Ph.D. in Chemical and Biomolecular Engineering from The Johns Hopkins University and a BS in Chemical Engineering from SUNY at Buffalo.